Photofragmentation MS of Ion Mobility Separated Peptides

Information

  • Research Project
  • 6994041
  • ApplicationId
    6994041
  • Core Project Number
    R44RR017139
  • Full Project Number
    2R44RR017139-02
  • Serial Number
    17139
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/2002 - 23 years ago
  • Project End Date
    8/31/2007 - 18 years ago
  • Program Officer Name
    SHEELEY, DOUGLAS
  • Budget Start Date
    9/30/2005 - 20 years ago
  • Budget End Date
    8/31/2006 - 19 years ago
  • Fiscal Year
    2005
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/28/2005 - 20 years ago
Organizations

Photofragmentation MS of Ion Mobility Separated Peptides

DESCRIPTION (provided by applicant): Ion mobility (IM) is a perfect instrumental platform for slowing and separating peptide ions-this innovation has enabled efficient VUV photofragmentation (IM-oTOFMS/MS) to be demonstrated in phase I. VUV photofragmentation yields a near perfect technology for "on demand" structural fragment ion analysis of complex peptide mixtures especially when combined with the proven capability of IM to distinguish phosphorylated vs. unphosphorylated peptides. In addition, recent internally funded research at lonwerks [34-37] has rather unexpectedly proved the efficacy of incorporating nanoparticulate MALDI matrices into the near surface of biotissues. Recently, lonwerks publications [34-40] and patents [41-44] have established a new approach to molecular microprobe imaging of biotissue surfaces. Thus, the simplification of complex laser microprobe molecular ion spectra from particulate treated biosurfaces is another application which will also benefit from the combination of ion mobility separation followed with on demand photofragmentation structural analysis. Phase II will develop unique IM-oTOFMS/MS hardware using patented multi-pixel position sensitive detectors in a specially designed oTOFMS. Enhanced mass and mobility resolution as well as photofragment MS of this instrument will be tested for applications in proteomics and tissue imaging. Commercialization depends on showing that only IMS-oTOFMS/MS can perform these applications.

IC Name
NATIONAL CENTER FOR RESEARCH RESOURCES
  • Activity
    R44
  • Administering IC
    RR
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    490491
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    389
  • Ed Inst. Type
  • Funding ICs
    NCRR:490491\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    IONWERKS, INC.
  • Organization Department
  • Organization DUNS
    154074553
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77002
  • Organization District
    UNITED STATES